These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38768274)

  • 1. Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis.
    Pedretti R; Wang L; Hanna M; Benson MD; Grodin JL; Tang WHW; Masri A; Saelices L
    Circulation; 2024 May; 149(21):1696-1699. PubMed ID: 38768274
    [No Abstract]   [Full Text] [Related]  

  • 2. Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis.
    Costa-Rodrigues D; Leite JP; Saraiva MJ; Almeida MR; Gales L
    Amyloid; 2024 Sep; 31(3):202-208. PubMed ID: 38946492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of wild-type and mutated transthyretins.
    Tasaki M; Ueda M; Obayashi K; Motokawa H; Kinoshita Y; Suenaga G; Yanagisawa A; Toyoshima R; Misumi Y; Masuda T; Yamashita T; Ando Y
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):508-10. PubMed ID: 26342004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
    Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
    Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
    Arvanitis M; Koch CM; Chan GG; Torres-Arancivia C; LaValley MP; Jacobson DR; Berk JL; Connors LH; Ruberg FL
    JAMA Cardiol; 2017 Mar; 2(3):305-313. PubMed ID: 28196196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
    Hendren NS; Roth LR; Grodin JL
    Curr Heart Fail Rep; 2020 Jun; 17(3):77-83. PubMed ID: 32356182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
    Misumi Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Ohshima T; Ando Y; Uchino M
    Hum Pathol; 2012 Jan; 43(1):96-104. PubMed ID: 21777941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis.
    Lau KHV; Prokaeva T; Zheng L; Doros G; Kaku MC; Spencer B; Berk J; Sanchorawala V
    Amyloid; 2024 Jun; 31(2):150-152. PubMed ID: 38073425
    [No Abstract]   [Full Text] [Related]  

  • 10. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures.
    Kurian SM; Novais M; Whisenant T; Gelbart T; Buxbaum JN; Kelly JW; Coelho T; Salomon DR
    Theranostics; 2016; 6(11):1792-809. PubMed ID: 27570551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.
    Schmidt M; Wiese S; Adak V; Engler J; Agarwal S; Fritz G; Westermark P; Zacharias M; Fändrich M
    Nat Commun; 2019 Nov; 10(1):5008. PubMed ID: 31676763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinded potency comparison of transthyretin kinetic stabilisers by subunit exchange in human plasma.
    Nelson LT; Paxman RJ; Xu J; Webb B; Powers ET; Kelly JW
    Amyloid; 2021 Mar; 28(1):24-29. PubMed ID: 32811187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreal deposits in Val71Ala transthyretin amyloidosis.
    Suan D; Booth DR; Kennedy IH; Downie J; Earls P; Gottlieb D; Stewart GJ; Lin MW
    Intern Med J; 2012 Jan; 42(1):106-8. PubMed ID: 22276564
    [No Abstract]   [Full Text] [Related]  

  • 15. The Tenosynovitis of Fingers Associated with Transthyretin Amyloidosis.
    Hara Y; Tajiri Y; Kawano K; Hoshikawa S; Kita Y
    J Hand Surg Asian Pac Vol; 2020 Sep; 25(3):340-344. PubMed ID: 32723050
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
    Chan GG; Koch CM; Connors LH
    J Proteome Res; 2017 Nov; 16(11):4104-4112. PubMed ID: 28922609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin-related amyloid in a saphenous vein. Histological diagnosis in a patient undergoing coronary artery bypass surgery.
    Farci F; De Martino A; Pratali S; Bortolotti U; Pucci A
    Cardiovasc Pathol; 2019; 41():21-23. PubMed ID: 31005793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
    Ripoll-Vera T; Buades J; Cisneros E; Gómez Y; Núñez J; Raya M
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
    Sekijima Y; Tokuda T; Kametani F; Tanaka K; Maruyama K; Ikeda S
    Amyloid; 2001 Dec; 8(4):257-62. PubMed ID: 11791618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.
    Nomura T; Ueda M; Tasaki M; Misumi Y; Masuda T; Inoue Y; Tsuda Y; Okada M; Okazaki T; Kanenawa K; Isoguchi A; Nakamura M; Obayashi K; Shinriki S; Matsui H; Yamashita T; Ando Y
    Orphanet J Rare Dis; 2019 May; 14(1):116. PubMed ID: 31133063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.